GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Novartis India Ltd (BOM:500672) » Definitions » Shiller PE Ratio

Novartis India (BOM:500672) Shiller PE Ratio : 39.23 (As of Jun. 21, 2024)


View and export this data going back to 1991. Start your Free Trial

What is Novartis India Shiller PE Ratio?

As of today (2024-06-21), Novartis India's current share price is ₹1100.70. Novartis India's E10 for the quarter that ended in Mar. 2024 was ₹28.06. Novartis India's Shiller PE Ratio for today is 39.23.

The historical rank and industry rank for Novartis India's Shiller PE Ratio or its related term are showing as below:

BOM:500672' s Shiller PE Ratio Range Over the Past 10 Years
Min: 9.03   Med: 22.85   Max: 39.55
Current: 38.5

During the past years, Novartis India's highest Shiller PE Ratio was 39.55. The lowest was 9.03. And the median was 22.85.

BOM:500672's Shiller PE Ratio is ranked worse than
72.66% of 534 companies
in the Drug Manufacturers industry
Industry Median: 24.07 vs BOM:500672: 38.50

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novartis India's adjusted earnings per share data for the three months ended in Mar. 2024 was ₹5.940. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ₹28.06 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Novartis India Shiller PE Ratio Historical Data

The historical data trend for Novartis India's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novartis India Shiller PE Ratio Chart

Novartis India Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 12.98 20.17 19.78 36.66

Novartis India Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.78 27.61 25.52 26.95 36.66

Competitive Comparison of Novartis India's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Novartis India's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novartis India's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Novartis India's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novartis India's Shiller PE Ratio falls into.



Novartis India Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Novartis India's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=1100.70/28.06
=39.23

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Novartis India's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Novartis India's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=5.94/153.0345*153.0345
=5.940

Current CPI (Mar. 2024) = 153.0345.

Novartis India Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 4.480 94.103 7.286
201409 4.390 96.780 6.942
201412 -0.370 96.780 -0.585
201503 -8.253 97.163 -12.999
201506 4.170 99.841 6.392
201509 32.450 101.753 48.804
201512 18.280 102.901 27.186
201603 7.140 102.518 10.658
201606 5.970 105.961 8.622
201609 7.030 105.961 10.153
201612 4.770 105.196 6.939
201703 1.030 105.196 1.498
201706 2.500 107.109 3.572
201709 9.280 109.021 13.026
201712 6.660 109.404 9.316
201803 9.600 109.786 13.382
201806 4.050 111.317 5.568
201809 3.800 115.142 5.051
201812 5.210 115.142 6.925
201903 7.910 118.202 10.241
201906 0.320 120.880 0.405
201909 -2.110 123.175 -2.621
201912 3.130 126.235 3.794
202003 2.740 124.705 3.362
202006 1.780 127.000 2.145
202009 3.050 130.118 3.587
202012 -0.290 130.889 -0.339
202103 3.920 131.771 4.553
202106 2.550 134.084 2.910
202109 2.840 135.847 3.199
202112 2.570 138.161 2.847
202203 -9.470 138.822 -10.440
202206 21.210 142.347 22.802
202209 7.430 144.661 7.860
202212 3.080 145.763 3.234
202303 10.120 146.865 10.545
202306 8.210 150.280 8.360
202309 9.590 151.492 9.688
202312 10.760 152.924 10.768
202403 5.940 153.035 5.940

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Novartis India  (BOM:500672) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Novartis India Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Novartis India's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Novartis India (BOM:500672) Business Description

Traded in Other Exchanges
N/A
Address
Inspire BKC, Part of 601 & 701, Bandra Kurla Complex, Bandra (East), Mumbai, MH, IND, 400 051
Novartis India Ltd is an Indian-based pharmaceutical company. The company is engaged in the trading of Drugs and Pharmaceuticals. It derives revenue from operations in India. The company single business segment namely Pharmaceuticals, Its Pharmaceutical business focuses on Bone and Pain, Calcium portfolio, Gynecology, and Neurosciences.

Novartis India (BOM:500672) Headlines

No Headlines